[Skip to content]

tab rollover pre-load tab rollover pre-load tab rollover pre-load tab rollover pre-load tab rollover pre-load tab rollover pre-load
Wednesday 27 October 2021
Salford GP Header Montage
Latest News:
RSS icon
Search
.
Medicine, tablets, pills

Formulary

This is an electronic version of our Formulary written in conjunction with the Medicine Management Committee and the Pharmacy department.   The purpose of the Formulary is:

  • To promote safe, rational and cost effective prescribing within the Trust.
  • To help select the most appropriate drug amongst the many available.

 

This formulary is intended to act as a rapid reference source.  It is intended for the guidance of medical practitioners, nurses and other healthcare workers.

 

For local GPs and Non-medical prescribers working in the community there is the Greater Manchester Joint Formulary produced by the Greater Manchester Medicines Management Group (GMMMG).  The formulary ensures that patients receive seamless care across the primary-secondary care interface and reduces the need for switching programmes. All medicines recommended for use in the NHS in a NICE Technology Assessment (TA) are approved for use in Greater Manchester, the GMMMG site provides a list of medicines with a positive recommendation from  NICE and provides links to these TAs in the GMMMG formulary.  In the SRFT formulary below all the drugs with a positive NICE TA that are applicable to SRFT are included in the formulary.

 

How to use

All medicines are listed alphabetically using the generic name where possible.  Some brand names are used.

 

  1. Type the drug name in the 'Keywords' box

  2. Click on the 'Search' button

  3. Within the results, click on the 'generic name' of the medicine you are looking for.

  4. Click on the 'Link' - this will take you to further information that talks about that medicine. 

 

 

Drug NameBNF CategoryComment / Usage RestrictionsDetails
TisseelSee online BNFTo seal / obliterate pilonidal sinus track in selected patients with a primary single track sacral pilonidal disease. Approved for use October 2015 as per proposed indication only by the request of Mr Slade and Mr Andrzej Goscimski.  
Tizanidine10.2.2 Skeletal muscle relaxantsNeurology only 
Tobradex Eye Drops 5ml11.4.1 Cortocosteroids  
Tocilizumab10.1.3 Drugs which suppress the rheumatic disease processAs per NICE guidance for rheumatology for RA 
Tolcapone4.9.2 Antimuscarinic drugs used in parkinsonismNeurology only - to be prescribed and supplied only by hospital neurologists/pharmacy 
Tolterodine Including Mr7.4.2 Drugs for urinary frequency, enuresis and incontinenceElderly care and Urology only - second line use for patients intolerant of oxybutynin 
TolvaptanSee online BNFFor the licensed indication to slow the progression of cyst development and renal insufficiency of autosomal dominant polycystic kidney disease (ADPKD) in adults with CKD stage 2 to 3 at initiation of treatment with evidence of rapidly progressing disease. Approved January 2016 as per NICE TA 358 for initiation by Renal Consultants.   
Topiramate (Brand names - Topamax)4.8.1 Control of the epilepsiesApproved for use in adults and children as per licensed indication as an adjunctive treatment of generalised tonic clonic seizures or focal seizures with or without secondary generalisation, adjunctive treatment for Lennox- Gestaut syndrome. Also approved for children for 2nd line prophylaxis for chronic migraines (from 6 years of age) for children who did not respond to Pizotifen and Propranolol or where Pizotifen/propranolol unsuitable. On advice of specialist.  Prescribe generic option for new patients (MMG Jan 2014).  
Tramadol4.7.2 Opioid analgesicsAccording to Trust Musculoskeletal Pain Guidelines only and for use by Mr Jari post-operatively for a maximum course of two weeks duration 
Tranexamic AcidBlood products  

 

All material in this section is aimed at health professionals, but is information currently held within the public domain.   Members of the public seeking advice on medicine-related matters are encouraged to speak with their GP, pharmacist or nurse, or contact NHS Direct on 0845 46 47.